These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9296569)

  • 21. The full D1 dopamine receptor agonist SKF-82958 induces neuropeptide mRNA in the normosensitive striatum of rats: regulation of D1/D2 interactions by muscarinic receptors.
    Wang JQ; McGinty JF
    J Pharmacol Exp Ther; 1997 May; 281(2):972-82. PubMed ID: 9152408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons.
    Aizman O; Brismar H; Uhlén P; Zettergren E; Levey AI; Forssberg H; Greengard P; Aperia A
    Nat Neurosci; 2000 Mar; 3(3):226-30. PubMed ID: 10700253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrastriatal administration of botulinum neurotoxin A normalizes striatal D
    Wedekind F; Oskamp A; Lang M; Hawlitschka A; Zilles K; Wree A; Bauer A
    J Neurosci Res; 2018 Jan; 96(1):75-86. PubMed ID: 28695985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation by D1 and D2 dopamine receptors of ATP-induced release of intracellular Ca2+ in cultured rat striatal neurons.
    Rubini P; Engelhardt J; Wirkner K; Illes P
    Neurochem Int; 2008 Jan; 52(1-2):113-8. PubMed ID: 17664020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum.
    Aubert I; Ghorayeb I; Normand E; Bloch B
    J Comp Neurol; 2000 Feb; 418(1):22-32. PubMed ID: 10701753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deficits in striatal dopamine D(2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease.
    Araujo DM; Cherry SR; Tatsukawa KJ; Toyokuni T; Kornblum HI
    Exp Neurol; 2000 Dec; 166(2):287-97. PubMed ID: 11085894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased sensitivity in the interaction of the dopaminergic/adenosinergic system at the level of the adenylate cyclase activity in the striatum of the "weaver" mouse.
    K B; V T; N P; M M; N M; F A
    Neurochem Int; 2016 Oct; 99():233-238. PubMed ID: 27498335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitochondrial toxins in models of neurodegenerative diseases. II: Elevated zif268 transcription and independent temporal regulation of striatal D1 and D2 receptor mRNAs and D1 and D2 receptor-binding sites in C57BL/6 mice during MPTP treatment.
    Smith TS; Trimmer PA; Khan SM; Tinklepaugh DL; Bennett JP
    Brain Res; 1997 Aug; 765(2):189-97. PubMed ID: 9313891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The time course of changes in D1 and D2 receptor binding in the striatum following a selective lesion of striatonigral neurons.
    Harrison MB; Wiley RG; Wooten GF
    Brain Res; 1992 Nov; 596(1-2):330-6. PubMed ID: 1334779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age-related changes of dopamine D1-like and D2-like receptor binding in the F344/N rat striatum revealed by positron emission tomography and in vitro receptor autoradiography.
    Suzuki M; Hatano K; Sakiyama Y; Kawasumi Y; Kato T; Ito K
    Synapse; 2001 Sep; 41(4):285-93. PubMed ID: 11494399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Striatal dopamine D1 and D2 receptors: widespread influences on methamphetamine-induced dopamine and serotonin neurotoxicity.
    Gross NB; Duncker PC; Marshall JF
    Synapse; 2011 Nov; 65(11):1144-55. PubMed ID: 21584865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Receptor-receptor link in membranes revealed by ligand competition: example for dopamine D1 and D2 receptors.
    Seeman P; Sunahara RK; Niznik HB
    Synapse; 1994 May; 17(1):62-4. PubMed ID: 8042146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopaminergic treatment weakens medium spiny neuron collateral inhibition in the parkinsonian striatum.
    Wei W; Ding S; Zhou FM
    J Neurophysiol; 2017 Mar; 117(3):987-999. PubMed ID: 27927785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aging-related changes in rat striatal D2 receptor mRNA-containing neurons: a quantitative nonradioactive in situ hybridization study.
    Zhang L; Ravipati A; Joseph J; Roth GS
    J Neurosci; 1995 Mar; 15(3 Pt 1):1735-40. PubMed ID: 7891131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine displays an identical apparent affinity towards functional dopamine D1 and D2 receptors in rat striatal slices: possible implications for the regulatory role of D2 receptors.
    Schoffelmeer AN; Hogenboom F; Mulder AH; Ronken E; Stoof JC; Drukarch B
    Synapse; 1994 Jul; 17(3):190-5. PubMed ID: 7974202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopaminergic control of kynurenate levels and N-methyl-D-aspartate toxicity in the developing rat striatum.
    Poeggeler B; Rassoulpour A; Guidetti P; Wu HQ; Schwarcz R
    Dev Neurosci; 1998; 20(2-3):146-53. PubMed ID: 9691189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine D1, D2 and mu-opioid receptors are co-expressed with adenylyl cyclase 5 and phosphodiesterase 7B mRNAs in striatal rat cells.
    de Gortari P; Mengod G
    Brain Res; 2010 Jan; 1310():37-45. PubMed ID: 19913519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. L-DOPA Oppositely Regulates Synaptic Strength and Spine Morphology in D1 and D2 Striatal Projection Neurons in Dyskinesia.
    Suarez LM; Solis O; Aguado C; Lujan R; Moratalla R
    Cereb Cortex; 2016 Oct; 26(11):4253-4264. PubMed ID: 27613437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of the bovine striatal D2 receptor, but not the D1 receptor, in bovine adrenal medulla.
    Maroto R; López MG; del Valle M; Naranjo JR; Mellström B; García AG
    Mol Pharmacol; 1995 Jan; 47(1):40-50. PubMed ID: 7838132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.